Learn more

ARTEMIS PHARMACEUTICALS GMBH

Overview
  • Total Patents
    80
About

ARTEMIS PHARMACEUTICALS GMBH has a total of 80 patent applications. Its first patent ever was published in 1999. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are BRESAGEN LTD, CHROMOS MOLECULAR SYSTEMS INC and GENPATH PHARMACEUTICALS INC.

Patent filings per year

Chart showing ARTEMIS PHARMACEUTICALS GMBHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Schwenk Frieder 26
#2 Seibler Jost 21
#3 Hobom Gerd 19
#4 Menke Anette 14
#5 Faust Nicole 12
#6 Kuehn Ralf 12
#7 Edenhofer Frank Oliver Stefan 9
#8 Kueter-Luks Birgit 9
#9 Kuhn Ralf 8
#10 Kern Heidrun 7

Latest patents

Publication Filing date Title
US2009025097A1 Shrna and sirna and mirna expression in a living organism under control of a codon-optimized repressor gene
EP1888750A1 Shrna and sirna expression in a living organism under control op a codon-optimized tetracycline repressor gene
EP1731607A1 shRNA and siRNA expression in a living organism under control of a codon-optimized tetracycline repressor gene
EP1614755A1 Target transgenesis of short hairpin RNA expression cassette using recombinase mediated cassette exchange
WO2004035782A2 Sirna mediated gene silencing in transgenic animals
AU2003210422A8 Recombinase fusion protein with enhanced cellular uptake
AU2003210405A1 Inbred embryonic stem-cell derived mice
AU2003206841A1 Genetically engineered phic31-integrase genes
EP1445320A1 Automated gene-targeting using non-toxic detectable markers
EP1439234A1 Targeted transgenesis using the rosa26 locus
EP1342781A1 Recombinase fusion protein with enhanced cellular uptake
WO0238613A2 Modified recombinase
AU6599601A Method for the identification of agents and genes influencing cardiovascular function
EP1233059A1 Influenza viruses with enhanced transcriptional and replicational capacities
WO0149832A2 Transduction of recombinases for inducible gene targeting
US6465169B2 Method for cryoconservation of Zebrafish sperm
EP1205490A1 Fusion protein comprising integrase (phiC31) and a signal peptide (NLS)
EP1201760A1 Influenza virus vector for human dendritic cells
EP1174514A1 Recombinant influenza viruses with bicistronic vRNAs coding for two genes in tandem arrangement
EP1170364A1 Mutations of cryptic splice sites in Cre and Cre-fusion proteins to improve the expression in inducibility